Difference between revisions of "Template:Antidepressants"
Jump to navigation
Jump to search
(blocks too chunky to serve as dots - also, they had no linewrap handling) |
blackwiki>Vanished 45kd09la13 (Undid revision 353738765 by 212.84.101.159 (talk)) |
||
| Line 1: | Line 1: | ||
{{Navbox with collapsible sections | {{Navbox with collapsible sections | ||
| − | | name = | + | | name = Antidepressants |
| title = [[Antidepressant]]s ([[ATC_code_N06#N06A_Antidepressants|N06A]]) | | title = [[Antidepressant]]s ([[ATC_code_N06#N06A_Antidepressants|N06A]]) | ||
| state = {{{state|collapsed}}} | | state = {{{state|collapsed}}} | ||
| selected = {{{1|}}} | | selected = {{{1|}}} | ||
| − | | group1 = Specific [[Reuptake]] [[Reuptake inhibitor|Inhibitor]]s (RIs) | + | | group1 = Specific [[Reuptake]] [[Reuptake inhibitor|Inhibitor]]s (RIs), [[Reuptake enhancer|Enhancer]]s (REs), and [[Releasing agent|Releasing Agent]]s (RAs) |
| abbr1 = RIEAs | | abbr1 = RIEAs | ||
| list1 = {{Navbox subgroup | | list1 = {{Navbox subgroup | ||
| group1 = <small>[[Selective serotonin reuptake inhibitor|Selective Serotonin Reuptake Inhibitor]]s (SSRIs)</small> | | group1 = <small>[[Selective serotonin reuptake inhibitor|Selective Serotonin Reuptake Inhibitor]]s (SSRIs)</small> | ||
| − | | list1 = | + | | list1 = [[Alaproclate]] • [[Citalopram]] • [[Escitalopram]] • [[Femoxetine]] • [[Fluvoxamine]] • [[Indalpine]] • [[Litoxetine]] • [[Lubazodone]] • [[Paroxetine]] • [[Pirandamine]] • [[Seproxetine]] • [[Sertraline]] • [[Vilazodone]] • [[Zimelidine]] |
| group2 = <small>[[Serotonin-norepinephrine reuptake inhibitor|Serotonin-Norepinephrine Reuptake Inhibitor]]s (SNRIs)</small> | | group2 = <small>[[Serotonin-norepinephrine reuptake inhibitor|Serotonin-Norepinephrine Reuptake Inhibitor]]s (SNRIs)</small> | ||
| − | | list2 = | + | | list2 = [[Bicifadine]] • [[Clovoxamine]] • [[Desvenlafaxine]] • [[Duloxetine]] • [[Levomilnacipran]] • [[Milnacipran]] • [[Sibutramine]] • [[Venlafaxine]] |
| group3 = <small>[[Serotonin-norepinephrine-dopamine reuptake inhibitor|Serotonin-Norepinephrine-Dopamine Reuptake Inhibitor]]s (SNDRIs)</small> | | group3 = <small>[[Serotonin-norepinephrine-dopamine reuptake inhibitor|Serotonin-Norepinephrine-Dopamine Reuptake Inhibitor]]s (SNDRIs)</small> | ||
| − | | list3 = | + | | list3 = [[Brasofensine]] • [[BTS-74,398]] • [[Cocaine]] • [[Diclofensine]] • [[DOV-21,947]] • [[DOV-102,677]] • [[DOV-216,303]] • [[JNJ-7,925,476]] • [[NS-2359]] • [[PRC200-SS]] • [[SEP-225,289]] • [[SEP-227,162]] • [[Tesofensine]] |
| group4 = <small>[[Norepinephrine reuptake inhibitor|Norepinephrine Reuptake Inhibitor]]s (NRIs)</small> | | group4 = <small>[[Norepinephrine reuptake inhibitor|Norepinephrine Reuptake Inhibitor]]s (NRIs)</small> | ||
| − | | list4 = | + | | list4 = [[Atomoxetine|Atomoxetine/Tomoxetine]] • [[Binedaline]] • [[Ciclazindol]] • [[Esreboxetine]] • [[Mazindol]] • [[Nisoxetine]] • [[Reboxetine]] • [[Talopram]] • [[Talsupram]] • [[Tandamine]] • [[Viloxazine]] |
| group5 = <small>[[Dopamine reuptake inhibitor|Dopamine Reuptake Inhibitor]]s (DRIs)</small> | | group5 = <small>[[Dopamine reuptake inhibitor|Dopamine Reuptake Inhibitor]]s (DRIs)</small> | ||
| − | | list5 = | + | | list5 = [[Medifoxamine]] • [[Vanoxerine]] |
| group6 = <small>[[Norepinephrine-dopamine reuptake inhibitor|Norepinephrine-Dopamine Reuptake Inhibitor]]s (NDRIs)</small> | | group6 = <small>[[Norepinephrine-dopamine reuptake inhibitor|Norepinephrine-Dopamine Reuptake Inhibitor]]s (NDRIs)</small> | ||
| − | | list6 = | + | | list6 = [[Amineptine]] • [[Bupropion|Bupropion/Amfebutamone]] • [[Cilobamine]] • [[Manifaxine]] • [[Methylphenidate]] • [[Nomifensine]] • [[Radafaxine]] |
| group7 = <small>[[Norepinephrine-dopamine releasing agent|Norepinephrine-Dopamine Releasing Agent]]s (NDRAs)</small> | | group7 = <small>[[Norepinephrine-dopamine releasing agent|Norepinephrine-Dopamine Releasing Agent]]s (NDRAs)</small> | ||
| − | | list7 = | + | | list7 = [[Amphetamine]] • [[Befuraline]] • [[Lisdexamfetamine]] • [[Methamphetamine]] • [[Phenethylamine]] • [[Piberaline]] • [[Tranylcypromine]] |
| group8 = <small>[[Serotonin-norepinephrine-dopamine releasing agent|Serotonin-Norepinephrine-Dopamine Releasing Agent]]s (SNDRAs)</small> | | group8 = <small>[[Serotonin-norepinephrine-dopamine releasing agent|Serotonin-Norepinephrine-Dopamine Releasing Agent]]s (SNDRAs)</small> | ||
| − | | list8 = | + | | list8 = [[4-Methyl-αMT]] • [[alpha-Ethyltryptamine|αET/Etryptamine]] • [[alpha-Methyltryptamine|αMT/Metryptamine]] |
| group9 = <small>[[Selective serotonin reuptake enhancer|Selective Serotonin Reuptake Enhancer]]s (SSREs)</small> | | group9 = <small>[[Selective serotonin reuptake enhancer|Selective Serotonin Reuptake Enhancer]]s (SSREs)</small> | ||
| − | | list9 = | + | | list9 = [[Tianeptine]] |
| + | |||
| + | | group10 = <small>Others</small> | ||
| + | | list10 = [[Indeloxazine]] • [[Tramadol]] • [[Viqualine]] | ||
}} | }} | ||
| − | | group2 = [[Serotonin antagonist and reuptake inhibitor|Serotonin Antagonists and Reuptake Inhibitor]]s (SARIs) | + | | group2 = [[Receptor antagonist|Receptor Antagonist]]s and/or [[Reuptake inhibitor|Reuptake Inhibitor]]s |
| − | + | | abbr2 = RARIs | |
| − | + | | list2 = {{Navbox subgroup | |
| + | |||
| + | | group1 = <small>[[Serotonin antagonist and reuptake inhibitor|Serotonin Antagonists and Reuptake Inhibitor]]s (SARIs)</small> | ||
| + | | list1 = [[Etoperidone]] • [[Nefazodone]] • [[Trazodone]] | ||
| + | |||
| + | | group2 = <small>[[Noradrenergic and specific serotonergic antidepressant|Noradrenergic and Specific Serotonergic Antidepressant]]s (NaSSAs)</small> | ||
| + | | list2 = [[Esmirtazapine]] • [[Mianserin]] • [[Mirtazapine]] • [[Setiptiline|Setiptiline/Teciptiline]] | ||
| + | |||
| + | | group3 = <small>[[Norepinephrine-dopamine disinhibitor|Norepinephrine-Dopamine Disinhibitor]]s (NDDIs)</small> | ||
| + | | list3 = [[Agomelatine]] | ||
| − | + | | group4 = <small>Serotonin Modulators and Stimulators (SMSs)</small> | |
| − | + | | list4 = [[Lu AA21004]] | |
| − | |||
| − | + | }} | |
| − | |||
| − | |||
| − | | | + | | group3 = [[Tricyclic antidepressant|Tricyclic]] and [[Tetracyclic antidepressant|Tetracyclic Antidepressant]]s (TCAs/TeCAs) |
| − | | | + | | abbr3 = TCAs |
| − | | | + | | list3 = '''Tricyclics''': [[Amineptine]] • [[Amitriptyline]] • [[Amitriptylinoxide]] • [[Azepindole]] • [[Butriptyline]] • [[Cianopramine]] • [[Clomipramine]] • [[Cyanodothiepin]] • [[Demexiptiline]] • [[Desipramine]] • [[Dibenzepine]] • [[Dimetacrine]] • [[Dosulepin|Dosulepin/Dothiepin]] • [[Doxepin]] • [[Fluotracen]] • [[Hepzidine]] • [[Homopipramol]] • [[Imipramine]] • [[Imipraminoxide]] • [[Intriptyline]] • [[Iprindole]] • [[Ketipramine]] • [[Litracen]] • [[Lofepramine]] • [[Lortalamine]] • [[Losindole]] • [[Mariptiline]] • [[Melitracen]] • [[Metapramine]] • [[Mezepine]] • [[Naranol]] • [[Nitroxazepine]] • [[Nortriptyline]] • [[Noxiptiline]] • [[Octriptyline]] • [[Opipramol]] • [[Pipofezine]] • [[Propizepine]] • [[Protriptyline]] • [[Quinupramine]] • [[Tianeptine]] • [[Tienopramine]] • [[Trimipramine]]; '''Tetracyclics''': [[7-Hydroxyamoxapine|7-OH-Amoxapine]] • [[Amoxapine]] • [[Ciclazindol]] • [[Esmirtazapine]] • [[Loxapine]] • [[Maprotiline]] • [[Mazindol]] • [[Mianserin]] • [[Mirtazapine]] • [[Oxaprotiline]] • [[Setiptiline|Setiptiline/Teciptiline]] |
| − | | group7 = Miscellaneous Agents | + | | group4 = [[Monoamine oxidase inhibitor|Monoamine Oxidase Inhibitors]] (MAOIs) |
| + | | abbr4 = MAOIs | ||
| + | | list4 = '''Nonselective:''' ''Irreversible:'' [[Benmoxin]] • [[Echinopsidine]] • [[Iproclozide]] • [[Iproniazid]] • [[Isocarboxazid]] • [[Mebanazine]] • [[Metfendrazine]] • [[Nialamide]] • [[Octamoxin]] • [[Phenelzine]] • [[Pheniprazine]] • [[Phenoxypropazine]] • [[Pivalylbenzhydrazine]] • [[Safrazine]] • [[Tranylcypromine]]; ''Reversible:'' [[Caroxazone]]; '''MAO<sub>A</sub>-Selective:''' ''Irreversible:'' [[Clorgyline]]; ''Reversible:'' [[Amiflamine]] • [[Bazinaprine]] • [[Befloxatone]] • [[Befol]] • [[Brofaromine]] • [[Cimoxatone]] • [[Esuperone]] • [[Harmala alkaloid|Harmala Alkaloid]]s ([[Harmine]], [[Harmaline]], [[Tetrahydroharmine]], [[Harmala alkaloid#Chemical Forms|Harman]], [[Norharman]], etc) • [[Methylene blue|Methylene Blue]] • [[Metralindole]] • [[Minaprine]] • [[Moclobemide]] • [[Pirlindole]] • [[Sercloremine]] • [[Tetrindole]] • [[Toloxatone]] • [[Tyrima]]; '''MAO<sub>B</sub>-Selective:''' ''Irreversible:'' [[Ladostigil]] • [[Mofegiline]] • [[Pargyline]] • [[Rasagiline]] • [[Selegiline]]; ''Reversible:'' [[Lazabemide]] • [[Milacemide]] | ||
| + | |||
| + | | group5 = [[Azapirone]]s and Other [[5-HT1A receptor|5-HT<sub>1A</sub> Receptor]] [[Serotonin receptor agonist|Agonist]]s | ||
| + | | abbr5 = AZPs | ||
| + | | list5 = [[Alnespirone]] • [[Aripiprazole]] • [[Befiradol]] • [[Buspirone]] • [[Eptapirone]] • [[Flesinoxan]] • [[Flibanserin]] • [[Gepirone]] • [[Ipsapirone]] • [[Oxaflozane]] • [[Tandospirone]] • [[Vilazodone]] • [[Zalospirone]] | ||
| + | |||
| + | | group6 = [[Dietary supplement|Dietary Supplement]]s ([[Vitamin]]s, [[Mineral]]s, [[Amino acid|Amino Acid]]s, etc) | ||
| + | | abbr6 = SUPPs | ||
| + | | list6 = [[Ascorbic acid|Ascorbic Acid]] (Vitamin C) • [[Fish oil|Fish Oil]] • [[Folic acid|Folic Acid]] (Vitamin B<sub>9</sub>) • [[L-5-Hydroxytryptophan|L-5-HTP]] (Oxitriptan) • [[L-DOPA]] (Levodopa) • [[L-Methionine]] • [[L-Phenylalanine]] • [[L-Tryptophan]] • [[L-Tyrosine]] • [[Lithium]] • [[Magnesium]] • [[Melatonin]] • [[Niacin]]/[[Niacinamide]] (Vitamin B<sub>3</sub>) • [[Omega-3 fatty acid|Omega-3 Fatty Acid]]s • [[Pyridoxine]] (Vitamin B<sub>6</sub>) • [[Rubidium]] • [[S-Adenosyl-L-methionine|SAMe]] • [[Zinc]] | ||
| + | |||
| + | | group7 = [[Research chemical|Research Compound]]s and Miscellaneous Agents | ||
| abbr7 = MISCs | | abbr7 = MISCs | ||
| list7 = {{Navbox subgroup | | list7 = {{Navbox subgroup | ||
| − | | group1 = <small>[[5- | + | | group1 = <small>[[5-HT4 receptor|5-HT<sub>4</sub>R]] [[Serotonin receptor agonist|Agonist]]s</small> |
| − | | list1 = < | + | | list1 = [[RS-67,333]] • [[SL65.0155]] |
| + | |||
| + | | group2 = <small>[[5-HT7 receptor|5-HT<sub>7</sub>R]] [[Serotonin receptor antagonist|Antagonist]]s</small> | ||
| + | | list2 = [[Amisulpride]] | ||
| + | |||
| + | | group3 = <small>[[Voltage-dependent calcium channel|α2δ-VDCC]] [[Calcium channel blocker|Blocker]]s</small> | ||
| + | | list3 = [[Gabapentin]] • [[Pregabalin]] | ||
| + | |||
| + | | group4 = <small>[[Beta-3 adrenergic receptor|β<sub>3</sub>-Adrenoceptor]] [[Adrenergic agonist|Agonist]]s | ||
| + | | list4 = [[Amibegron]] • [[Solabegron]] | ||
| + | |||
| + | | group5 = <small>[[Sigma receptor|σ<sub>1</sub>R]] [[Agonist]]s</small> | ||
| + | | list5 = [[Opipramol]] | ||
| + | |||
| + | | group6 = <small>[[CB1 receptor|CB<sub>1</sub>R]] [[Cannabinoid|Agonist]]s | ||
| + | | list6 = [[Nabilone]] • [[Tetrahydrocannabinol]]/[[Dronabinol]] | ||
| + | |||
| + | | group7 = <small>[[Catechol O-methyltransferase|COMT]] [[COMT inhibitor|Inhibitor]]s | ||
| + | | list7 = [[Entacapone]] • [[Tolcapone]] | ||
| + | |||
| + | | group8 = <small>[[Corticotropin releasing hormone receptor 1|CRF<sub>1</sub>R]] [[Corticotropin releasing hormone antagonist|Antagonist]]s</small> | ||
| + | | list8 = [[Antalarmin]] • [[CP-154,526]] • [[Pexacerfont]] • [[Pivagabine]] | ||
| − | | | + | | group9 = <small>[[D2 receptor|D<sub>2</sub>]]/[[D3 receptor|D<sub>3</sub>]][[Autoreceptor|AR]] [[Dopamine receptor antagonist|Antagonist]]s</small> |
| − | | | + | | list9 = [[Amisulpride]] • [[Sulpiride]] |
| − | | | + | | group10 = <small>[[D2 receptor|D<sub>2</sub>]]/[[D3 receptor|D<sub>3</sub>]]/[[D4 receptor|D<sub>4</sub>]][[Dopamine receptor agonist|R Agonist]]s</small> |
| − | | | + | | list10 = [[Piribedil]] • [[Pramipexole]] • [[Ropinirole]] • [[Rotigotine]] • [[Roxindole]] |
| − | | | + | | group11 = <small>[[delta-opioid receptor|DOR]] [[Opioid|Agonist]]s</small> |
| − | + | | list11 = [[BU-48]] • [[Buprenorphine]] • [[BW373U86]] • [[DPI-287]] • [[Heroin]] • [[Kratom]] • [[SNC-80]] | |
| − | | | + | | group12 = <small>[[Enkephalinase]] [[Enzyme inhibitor|Inhibitor]]s</small> |
| − | | | + | | list12 = [[Phenylalanine|D-Phenylalanine]] • [[RB-101]] |
| − | | | + | | group13 = <small>[[Fatty acid amide hydrolase|FAAH]] [[Enzyme inhibitor|Inhibitor]]s</small> |
| − | | | + | | list13 = [[Acetaminophen]]/[[Paracetamol]] • [[AM404|AM-404]] • [[URB597|URB-597]] |
| − | | | + | | group14 = <small>[[kappa-opioid receptor|KOR]] [[Opioid|Antagonist]]s</small> |
| − | | | + | | list14 = [[5'-Guanidinonaltrindole|5-GNTI]] • [[Buprenorphine]] • [[JDTic]] • [[Norbinaltorphimine]] |
| − | | | + | | group15 = <small>[[mu-opioid receptor|MOR]] [[Opioid|Agonist]]s |
| − | | | + | | list15 = [[Buprenorphine]] • [[Codeine]] • [[Dextropropoxyphene]] • [[Dihydrocodeine]] • [[Fentanyl]] • [[Heroin]] • [[Hydrocodone]] • [[Hydromorphone]] • [[Kratom]] • [[Methadone]] • [[Morphine]] • [[Opium]] • [[Oxycodone]] • [[Oxymorphone]] • [[Pethidine|Pethidine/Meperidine]] • [[Tapentadol]] • [[Tramadol]] |
| + | |||
| + | | group16 = <small>[[MT1 receptor|MT<sub>1</sub>]]/[[MT2 receptor|MT<sub>2</sub>R]] [[Agonist]]s | ||
| + | | list16 = [[Agomelatine]] • [[Melatonin]] • [[Ramelteon]] • [[Tasimelteon]] | ||
| + | |||
| + | | group17 = <small>[[NK1 receptor|NK<sub>1</sub>R]] [[NK1 receptor antagonist|Antagonist]]s</small> | ||
| + | | list17 = [[Aprepitant]] • [[Casopitant]] • [[Fosaprepitant]] • [[L-733,060]] • [[Maropitant]] • [[Vestipitant]] | ||
| + | |||
| + | | group18 = <small>[[NMDA receptor|NMDAR]] [[NMDA receptor antagonist|Antagonist]]s</small> | ||
| + | | list18 = [[Dextromethorphan]] • [[Ketamine]] • [[Magnesium]] • [[Memantine]] • [[Zinc]] | ||
| + | |||
| + | | group19 = <small>[[PDE4]] [[Phosphodiesterase inhibitor|Inhibitor]]s</small> | ||
| + | | list19 = [[Mesembrine]] ([[Sceletium tortuosum|Kanna]]) • [[Rolipram]] | ||
| + | |||
| + | | group20 = <small>[[TRPC6]] [[Agonist|Activator]]s</small> | ||
| + | | list20 = [[Adhyperforin]] ([[Hypericum perforatum|St. John's Wort]]) • [[Hyperforin]] ([[Hypericum perforatum|St. John's Wort]]) | ||
}} | }} | ||
| − | }}<noinclude> | + | | belowstyle = background: LemonChiffon |
| + | | below = {{Psychology navs}} | ||
| + | |||
| + | |||
| + | }} | ||
| + | <noinclude> | ||
| − | <br/>{{Collapsible sections option | list = "RIEAs", " | + | <br/>{{Collapsible sections option | list = "RIEAs", "RARIs", ""TCAs", "MAOIs", "AZPs", "SUPPs" or "MISCs"}} |
[[Category:Drug templates|{{PAGENAME}}]] | [[Category:Drug templates|{{PAGENAME}}]] | ||
Revision as of 19:57, 3 April 2010
Template:Navbox with collapsible sections
How to manage this template's collapsible groups/sections option
- This template includes collapsible groups/sections. When it first appears, one of these groups/sections may be set to be visible ("expanded") while the others remain hidden ("collapsed") apart from their titlebars. To achieve this, include the parameter
|namewhere name is one of the following words that identify the groups/sections (omit any speech or quotation marks): "RIEAs", "RARIs", ""TCAs", "MAOIs", "AZPs", "SUPPs" or "MISCs"
fr:Modèle:Antidépresseurs hu:Sablon:Antidepresszánsok ru:Шаблон:Антидепрессанты